Show simple item record

dc.contributor.authorTran, Dena H
dc.contributor.authorPeng, Carol Chiung-Hui
dc.contributor.authorWolde-Rufael, Daniel A
dc.contributor.authorDevkota, Hari
dc.contributor.authorDiaz-Abad, Montserrat
dc.contributor.authorBaghdadi, Jonathan
dc.contributor.authorChow, R Dobbin
dc.contributor.authorVerceles, Avelino C
dc.date.accessioned2021-07-07T16:57:22Z
dc.date.available2021-07-07T16:57:22Z
dc.date.issued2021-06-21
dc.identifier.urihttp://hdl.handle.net/10713/16144
dc.description.abstractIntroduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China in December 2019 and is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19). Approximately one-third of the patients with COVID-19 require intensive care unit (ICU) admission, and almost 30% of the patients develop acute respiratory distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) is used as salvage therapy for severe ARDS. The role of ECMO in the treatment of COVID-19 remains unclear, although there is emerging evidence that this approach may be an effective salvage therapy for severe ARDS. Case Presentation: We present a case of a previously healthy 39-year-old Hispanic male who presented to the hospital with flu-like symptoms, including headache, fatigue, and myalgia for 8 days in late April 2020. He denied dyspnea on exertion. The patient's symptoms progressed, resulting in pneumonia and acute respiratory distress syndrome (ARDS). The patient was managed with prone positioning, convalescent plasma and veno-venous extracorporeal membrane oxygenation (VV-ECMO) for 35 days. The patient successfully recovered and was able to ambulate independently and was discharged home from an acute care hospital without oxygen supplementation on hospital day 63. Conclusion: We present one of the first few documented cases of ECMO for severe ARDS due to COVID-19. After a prolonged hospital course requiring VV-ECMO, the patient was discharged home from an acute care hospital without oxygen requirement and ambulated independently, likely as a result of daily aggressive mobility-focused rehabilitation.en_US
dc.description.urihttps://doi.org/10.1080/20009666.2021.1918442en_US
dc.language.isoenen_US
dc.publisherTaylor and Francis Inc.en_US
dc.relation.ispartofJournal of Community Hospital Internal Medicine Perspectivesen_US
dc.rights© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.en_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectacute respiratory distress syndromeen_US
dc.subjectambulationen_US
dc.subjectdischarge homeen_US
dc.subjectextracorporeal membrane oxygenationen_US
dc.subjectrespiratory failureen_US
dc.titleA successful case of extracorporeal membrane oxygenation for COVID-19: walking home without oxygen supplementationen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/20009666.2021.1918442
dc.identifier.pmid34211653
dc.source.volume11
dc.source.issue4
dc.source.beginpage480
dc.source.endpage484
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record